Avanos Medical (AVNS) EBITDA Margin Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -178.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -283.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 72.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,505.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -184.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -3,846.00 |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 871.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 871.00 |
| Dec 31, 2025 | -776.00 |
| Sep 30, 2025 | -737.00 |
| Jun 30, 2025 | -4,848.00 |
| Mar 31, 2025 | 179.00 |
| Dec 31, 2024 | -17,045.00 |
| Sep 30, 2024 | 520.00 |
| Jun 30, 2024 | 759.00 |
| Mar 31, 2024 | 927.00 |
| Dec 31, 2023 | 3,198.00 |
| Sep 30, 2023 | 75.00 |
| Jun 30, 2023 | -14.00 |
| Mar 31, 2023 | -416.00 |
| Dec 31, 2022 | 1,083.00 |
| Sep 30, 2022 | 1,799.00 |
| Jun 30, 2022 | 1,160.00 |
| Mar 31, 2022 | 1,934.00 |
| Dec 31, 2021 | -5,768.00 |
| Sep 30, 2021 | -239.00 |
| Jun 30, 2021 | -939.00 |
| Mar 31, 2021 | -239.00 |
| Dec 31, 2020 | -2,371.00 |
| Sep 30, 2020 | 686.00 |
| Jun 30, 2020 | 702.00 |
| Mar 31, 2020 | 1,241.00 |
| Dec 31, 2019 | -3,069.00 |
| Sep 30, 2019 | -1,582.00 |
| Jun 30, 2019 | -1,009.00 |
| Mar 31, 2019 | -2,358.00 |
| Dec 31, 2018 | 3,465.00 |
| Sep 30, 2018 | 12,265.00 |
| Jun 30, 2018 | -21.00 |
| Mar 31, 2018 | -1,485.00 |
| Dec 31, 2017 | -727.00 |
| Sep 30, 2017 | -1,012.00 |
| Jun 30, 2017 | -703.00 |
| Mar 31, 2017 | -2,710.00 |
| Dec 31, 2016 | 1,565.00 |
| Sep 30, 2016 | -1,150.00 |